(Q43094309)

13 November 2017

title

Amelioration of ketamine-induced working memory deficits by dopamine D1 receptor agonists (English)

1 reference

13 November 2017

0 references

5

Stacy A Castner

1 reference

13 November 2017

Brooke M Roberts

1

1 reference

13 November 2017

Patricia A Seymour

series ordinal

2

1 reference

13 November 2017

Christopher J Schmidt

series ordinal

3

1 reference

13 November 2017

Graham V Williams

series ordinal

4

1 reference

13 November 2017

publication date

20 April 2010

1 reference

13 November 2017

1 reference

13 November 2017

volume

210

1 reference

13 November 2017

issue

3

1 reference

13 November 2017

page(s)

407-418

1 reference

https://scigraph.springernature.com/pub.10.1007/s00213-010-1840-9

13 November 2017

exact match

0 references

cites work

Evolving behavior in the clinical and experimental amphetamine (model) psychosis.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-1840-9

Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the "right stuff"?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-1840-9

Recent advances in the phencyclidine model of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-1840-9

Impaired mismatch negativity generation reflects widespread dysfunction of working memory in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-1840-9

Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-1840-9

The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-1840-9

What are the functional consequences of neurocognitive deficits in schizophrenia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-1840-9

Dopamine D1 receptor-dependent trafficking of striatal NMDA glutamate receptors to the postsynaptic membrane.

21 January 2018

1 reference

12 December 2020

Subunit-selective modulation of GABA type A receptor neurotransmission and cognition in schizophrenia

1 reference

12 December 2020

Ketalar (CI-581): a new short-acting anesthetic

1 reference

12 December 2020

Tuning the engine of cognition: a focus on NMDA/D1 receptor interactions in prefrontal cortex

1 reference

12 December 2020

Neuromodulatory actions of dopamine in the neostriatum are dependent upon the excitatory amino acid receptor subtypes activated

1 reference

12 December 2020

Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex.

1 reference

12 December 2020

Negative schizophrenic symptomatology and the PCP (phencyclidine) model of schizophrenia.

1 reference

12 December 2020

Localization of nigrostriatal dopamine receptor subtypes and adenylate cyclase

1 reference

12 December 2020

Dopamine D1 receptors: efficacy of full (dihydrexidine) vs. partial (SKF38393) agonists in primates vs. rodents

1 reference

12 December 2020

D(1) receptors in prefrontal cells and circuits

1 reference

12 December 2020

Ketamine-induced exacerbation of psychotic symptoms and cognitive impairment in neuroleptic-free schizophrenics.

1 reference

12 December 2020

NMDA and AMPA/kainate glutamatergic agonists increase the extracellular concentrations of GABA in the prefrontal cortex of the freely moving rat: modulation by endogenous dopamine

1 reference

12 December 2020

Effects of dihydrexidine, a full dopamine D-1 receptor agonist, on delayed response performance in chronic low dose MPTP-treated monkeys

1 reference

12 December 2020

Dopamine D1 receptor mechanisms in the cognitive performance of young adult and aged monkeys.

1 reference

12 December 2020

Preliminary evidence of attenuation of the disruptive effects of the NMDA glutamate receptor antagonist, ketamine, on working memory by pretreatment with the group II metabotropic glutamate receptor agonist, LY354740, in healthy human subjects

1 reference

12 December 2020

Effects of subanesthetic ketamine on regional cerebral glucose metabolism in humans

1 reference

12 December 2020

Attenuation of ketamine-evoked behavioral responses by mGluR5 positive modulators in mice.

1 reference

12 December 2020

Dose-dependent effects of the dopamine D1 receptor agonists A77636 or SKF81297 on spatial working memory in aged monkeys.

1 reference

12 December 2020

Enhancement of working memory in aged monkeys by a sensitizing regimen of dopamine D1 receptor stimulation.

1 reference

12 December 2020

Neurocognitive and symptom correlates of daily problem-solving skills in schizophrenia.

1 reference

12 December 2020

Selective modulation of excitatory and inhibitory microcircuits by dopamine

1 reference

12 December 2020

Impairment of working memory maintenance and response in schizophrenia: functional magnetic resonance imaging evidence

1 reference

12 December 2020

Dopamine depresses excitatory synaptic transmission onto rat subicular neurons via presynaptic D1-like dopamine receptors

1 reference

12 December 2020

Under the curve: critical issues for elucidating D1 receptor function in working memory

1 reference

12 December 2020

Effects of posterior parietal lesions on visually guided movements in monkeys.

1 reference

12 December 2020

The behavioral and neurochemical effects of phencyclidine in humans and animals: some implications for modeling psychosis

1 reference

12 December 2020

Reversal of ketamine-induced working memory impairments by the GABAAalpha2/3 agonist TPA023.

1 reference

12 December 2020

Reversal of antipsychotic-induced working memory deficits by short-term dopamine D1 receptor stimulation

1 reference

12 December 2020

Correlation of prepulse inhibition and Wisconsin Card Sorting Test in schizophrenia and controls: effects of smoking status

1 reference

12 December 2020

Reward-dependent spatial selectivity of anticipatory activity in monkey caudate neurons

1 reference

12 December 2020

Long-lasting psychotomimetic consequences of repeated low-dose amphetamine exposure in rhesus monkeys.

1 reference

12 December 2020

Ketamine impairs multiple cognitive domains in rhesus monkeys.

1 reference

12 December 2020

Clozapine blunts N-methyl-D-aspartate antagonist-induced psychosis: a study with ketamine.

1 reference

12 December 2020

Cortical glutamate-dopamine interaction and ketamine-induced psychotic symptoms in man.

1 reference

12 December 2020

Metabolic hyperfrontality and psychopathology in the ketamine model of psychosis using positron emission tomography (PET) and [18F]fluorodeoxyglucose (FDG).

1 reference

12 December 2020

A clinical approach to the treatment of phencyclidine (PCP) abuse [proceedings]

1 reference

12 December 2020

Presynaptic regulation of recurrent excitation by D1 receptors in prefrontal circuits

1 reference

12 December 2020

Potentiation of NMDA receptor currents by dopamine D1 receptors in prefrontal cortex

1 reference

12 December 2020

Ketamine--its pharmacology and therapeutic uses.

1 reference

12 December 2020

Mismatch negativity predicts psychotic experiences induced by NMDA receptor antagonist in healthy volunteers

1 reference

12 December 2020

Comparative and interactive human psychopharmacologic effects of ketamine and amphetamine: implications for glutamatergic and dopaminergic model psychoses and cognitive function

1 reference

12 December 2020

Ketamine disposition in children presenting for procedural sedation and analgesia in a children's emergency department.

1 reference

12 December 2020

The D2 dopamine receptor occupancy of risperidone and its relationship to extrapyramidal symptoms: a PET study.

1 reference

12 December 2020

A reversible model of the cognitive impairment associated with schizophrenia in monkeys: potential therapeutic effects of two nicotinic acetylcholine receptor agonists.

1 reference

12 December 2020

Visual and oculomotor functions of monkey substantia nigra pars reticulata. III. Memory-contingent visual and saccade responses

1 reference

12 December 2020

Effects of the NMDA antagonist ketamine on task-switching performance: evidence for specific impairments of executive control

1 reference

12 December 2020

Effects of dopamine agonists on delayed response performance in chronic low-dose MPTP-treated monkeys.

1 reference

12 December 2020

Independence and overlap among neurocognitive correlates of community functioning in schizophrenia.

1 reference

12 December 2020

Ketamine-induced distractibility: An oculomotor study in monkeys

1 reference

12 December 2020

Pharmacokinetics and analgesic effects of i.m. and oral ketamine

1 reference

12 December 2020

10.1007/S00213-010-1840-9

Identifiers

DOI

1 reference

Dimensions Publication ID

13 November 2017

1019589315

0 references

1 reference